Back
Global Medical REIT 10K Form
Sell
41
GMRE
Global Medical REIT
Last Price:
8.79
Seasonality Move:
5.34%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-05-07 | 10Q | GMRE/Global Medical REIT Quarterly |
| 2021-03-08 | 10K | GMRE/Global Medical REIT Annual |
| 2020-11-06 | 10Q | GMRE/Global Medical REIT Quarterly |
| 2020-08-07 | 10Q | GMRE/Global Medical REIT Quarterly |
| 2020-05-08 | 10Q | GMRE/Global Medical REIT Quarterly |
| 2020-04-27 | 10K | GMRE/Global Medical REIT Annual |
Receive GMRE News And Ratings
See the #1 stock for the next 7 days that we like better than GMRE
GMRE Financial Statistics
Sales & Book Value
| Annual Sales: | $140.93M |
|---|---|
| Cash Flow: | $-19.74M |
| Price / Cash Flow: | 25.84 |
| Annual Sales: | $7.00 |
| Price / Book: | 1.27 |
Profitability
| EPS (TTM): | -0.02000 |
|---|---|
| Net Income (TTM): | $4.42M |
| Gross Margin: | $112.85M |
| Return on Equity: | 0.74% |
| Return on Assets: | 0.35% |
Global Medical REIT Earnings Forecast
Key Global Medical REIT Financial Ratios
- The Gross Profit Margin over the past 10 years for GMRE is 80.07%.
- The Selling, General & Administrative Expenses for GMRE have been equal to 11.96% of Gross Profit Margin.
- The Interest Expense is 149.88% of Operating Income.
- The Net Earning history of GMRE is 14.63% of Total Revenues.
- Per Share Earnings over the last 12 years have been positive in 8 years.
Global Medical REIT Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Health Care REITs |
| Sector: | Real Estate |
| Current Symbol: | GMRE |
| CUSIP: | 37954A |
| Website: | globalmedicalreit.com |
Debt
| Debt-to-Equity Ratio: | 1.16 |
|---|---|
| Current Ratio: | 0.03 |
| Quick Ratio: | 0.02 |
Price-to-Earnings
| Trailing P/E Ratio: | 38.65 |
|---|---|
| Forward P/E Ratio: | 127 |
GMRE Technical Analysis vs Fundamental Analysis
Sell
41
Global Medical REIT (GMRE)
is a Sell
Is Global Medical REIT a Buy or a Sell?
-
Global Medical REIT stock is rated a Sell
The current Global Medical REIT [GMRE] share price is $8.89. The Score for GMRE is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.